- ISIN
- US4928541048
- CUSIP
- 492854104
- Sector
- Consumer Cyclical
- IPO Date
- Feb 25, 1992
Highlights
- Market Cap
- $110.55M
- Enterprise Value
- $170.07M
- EPS (TTM)
- $3.73
- PE Ratio
- 9.95
- PEG Ratio
- 0.04
- Total Revenue (TTM)
- $287.75M
- Gross Profit (TTM)
- $83.23M
- EBITDA (TTM)
- $26.69M
- Year Range
- $33.70 - $60.89
- ROA (TTM)
- 6.30%
- ROE (TTM)
- 15.68%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
KEQU Performance Chart
Kewaunee Scientific Corporation (KEQU) is down 0.9% since the beginning of the year. At $37 per share, KEQU is trading 39.1% below its 52-week high of $61. Investors who bought $1,000 worth of KEQU shares 5 years ago would now be looking at an investment worth $2,666.
Loading charts...
Returns By Period
Kewaunee Scientific Corporation (KEQU) has returned -0.94% so far this year and 1.01% over the past 12 months. Over the last ten years, KEQU has returned 7.83% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Kewaunee Scientific Corporation
- 1D
- -1.25%
- 1M
- -7.28%
- YTD
- -0.94%
- 6M
- -4.29%
- 1Y
- 1.01%
- 3Y*
- 29.82%
- 5Y*
- 21.67%
- 10Y*
- 7.83%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
KEQU Monthly Returns History
Based on dividend-adjusted daily data since Feb 25, 1992, KEQU's average daily return is +0.07%, while the average monthly return is +1.24%. At this rate, an investment would double in approximately 4.7 years.
Historically, 53% of months were positive and 47% were negative. The best month was Dec 2023 with a return of +67.0%, while the worst month was Nov 1992 at -42.9%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 8 months.
On a daily basis, KEQU closed higher 36% of trading days. The best single day was Jun 26, 2025 with a return of +35.4%, while the worst single day was Nov 19, 1992 at -40.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.69% | 4.93% | -17.40% | 8.00% | 9.62% | -8.65% | -0.94% | ||||||
| 2025 | 3.93% | -15.46% | -27.56% | -19.58% | 21.44% | 52.63% | -5.72% | 2.44% | -24.77% | -1.95% | -11.01% | 0.52% | -39.53% |
| 2024 | -3.20% | 1.63% | 20.28% | 3.78% | 20.34% | 9.87% | 17.84% | -3.45% | -38.01% | -4.72% | 31.56% | 48.26% | 112.83% |
| 2023 | 3.45% | -7.58% | 0.99% | 5.51% | 2.52% | -9.06% | 3.37% | -0.96% | 11.22% | 5.80% | -4.62% | 67.00% | 82.26% |
| 2022 | 15.35% | -0.34% | -0.68% | -1.66% | 3.08% | 13.06% | 11.67% | 6.25% | -10.75% | -3.98% | -1.18% | -4.49% | 25.59% |
| 2021 | 5.57% | -4.92% | -1.67% | -2.76% | -0.11% | 20.04% | -7.51% | -0.45% | 0.75% | -4.12% | -0.39% | -0.39% | 1.57% |
Benchmark Metrics
Kewaunee Scientific Corporation has an annualized alpha of 15.88%, beta of 0.33, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since February 25, 1992.
- This stock participated in 71.34% of S&P 500 Index downside but only 67.15% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.33 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 15.88%
- Beta
- 0.33
- R²
- 0.02
- Upside Capture
- 67.15%
- Downside Capture
- 71.34%
Return for Risk
Risk / Return Rank
KEQU ranks 43 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Kewaunee Scientific Corporation (KEQU) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KEQU | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.01 | ||
| Sortino ratioReturn per unit of downside risk | -2.29 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.37 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | 0.02 | 2.78 | -2.76 |
| Martin ratioReturn relative to average drawdown | 0.03 | 12.44 | -12.41 |
Dividends
Dividend History
Kewaunee Scientific Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.57 | $0.72 | $0.64 | $0.56 | $0.50 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.24% | 2.17% | 2.21% | 2.29% | 2.81% |
Monthly Dividends
The table displays the monthly dividend distributions for Kewaunee Scientific Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Kewaunee Scientific Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Kewaunee Scientific Corporation was 79.95%, occurring on Apr 2, 2020. Recovery took 1007 trading sessions.
The current Kewaunee Scientific Corporation drawdown is 46.81%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -79.95%Apr 2020 | 1y 9mo | 4y 3d | 5y 9moJun 2018 - Apr 2024 |
1994 bear market1994 | -73.30%Dec 1994 | 2y 9mo | 2y 6mo | 5y 4moMar 1992 - Jun 1997 |
Financial crisis2007–2009 | -67.23%Dec 2008 | 11mo 9d | 4y 9mo | 5y 8moDec 2007 - Sep 2013 |
2025 selloff2025 | -55.36%May 2025 | 2mo 21d | — | 1y 4moFeb 2025 - now |
Dot-com crash2000–2002 | -53.01%Sep 2001 | 1y 2mo | 2y 4mo | 3y 6moJul 2000 - Feb 2004 |
Drawdown Indicators
| KEQU | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.95% | -56.78% | -23.17% |
Max Drawdown (1Y)Largest decline over 1 year | -43.35% | -9.10% | -34.25% |
Max Drawdown (3Y)Largest decline over 3 years | -55.36% | -18.90% | -36.46% |
Max Drawdown (5Y)Largest decline over 5 years | -55.36% | -25.43% | -29.93% |
Max Drawdown (10Y)Largest decline over 10 years | -79.95% | -33.92% | -46.03% |
Current DrawdownCurrent decline from peak | -46.81% | -1.80% | -45.01% |
Average DrawdownAverage peak-to-trough decline | -32.25% | -10.71% | -21.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.75% | 2.03% | +28.72% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Kewaunee Scientific Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Kewaunee Scientific Corporation is priced in the market compared to other companies in the Furnishings, Fixtures & Appliances industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for KEQU, comparing it with other companies in the Furnishings, Fixtures & Appliances industry. Currently, KEQU has a P/E ratio of 9.9. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for KEQU compared to other companies in the Furnishings, Fixtures & Appliances industry. KEQU currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for KEQU relative to other companies in the Furnishings, Fixtures & Appliances industry. Currently, KEQU has a P/S ratio of 0.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for KEQU in comparison with other companies in the Furnishings, Fixtures & Appliances industry. Currently, KEQU has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with KEQU
Add Kewaunee Scientific Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with KEQU